Trials / Completed
CompletedNCT02262364
Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)
A Pilot Study of a Single Intra-articular Injection of Autologous Protein Solution in Patients With Knee Osteoarthritis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Zimmer Biomet · Industry
- Sex
- All
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to assess the safety of a single injection of APS.
Detailed description
The primary objective of this study is to assess the safety of a single injection of APS in patients with painful unilateral knee osteoarthritis and who have not been able to get satisfactory pain relief with other treatments through one-month post treatment and monitor subjects for adverse events through 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | APS | See above |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2016-10-01
- Completion
- 2016-10-01
- First posted
- 2014-10-13
- Last updated
- 2019-02-15
- Results posted
- 2019-02-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02262364. Inclusion in this directory is not an endorsement.